Outcomes of patients receiving additional esophagectomy after endoscopic resection for clinically mucosal, but pathologically submucosal, squamous cell carcinoma of the esophagus

Surgery Today

Volumn 43, Issue 6, 2013, Pages 638-642

  Motoyama, Satoru ^a   Jin, Mario ^a   Matsuhashi, Tamotsu ^a   Nanjo, Hiroshi ^a   Ishiyama, Koichi ^a   Sato, Yusuke ^a   Yoshino, Kei ^a   Sasaki, Tomohiko ^a   Wakita, Akiyuki ^a   Saito, Hajime ^a   Minamiya, Yoshihiro ^a   Ohnishi, Hirohide ^a   Ogawa, Jun Ichi ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Endoscopic submucosal dissection; Esophageal cancer; Esophagectomy; Lymph node metastasis; Outcome

Indexed keywords

ABDOMEN; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; ENDOSCOPIC SURGERY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; RECURRENT DISEASE; TREATMENT OUTCOME; TUMOR INVASION;

AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84878014554     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-012-0295-5     Document Type: Article

References (22)

1. Yamamoto H. Technology insight: endoscopic submucosal dissection of gastrointestinal neoplasms. Nat Clin Pract Gastroenterol Hepatol. 2007;4:511-20.
2. Pech O, Manner H, Ell C. Endoscopic resection. Gastrointest Endosc Clin N Am. 2011;21:81-94.
3. Eguchi T, Nakanishi Y, Shimoda T, Iwasaki M, Igaki H, Tachimori Y, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006;19:475-80.
4. Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten Kate FJ, van Lanschot JJ. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc. 2004;60:703-10.
5. Isomoto H, Yamaguchi N, Nakayama T, Hayashi T, Nishiyama H, Ohnita K, et al. Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. BMC Gastroenterol. 2011;11:46.
6. Urabe Y, Hiyama T, Tanaka S, Yoshihara M, Arihiro K, Chayama K. Advantages of endoscopic submucosal dissection versus endoscopic oblique aspiration mucosectomy for superficial esophageal tumors. J Gastroenterol Hepatol. 2011;26:275-80.
7. Gockel I, Sgourakis G, Lyros O, Polotzek U, Schimanski CC, Lang H, et al. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. Expert Rev Gastroenterol Hepatol. 2011;5:371-84.
8. Nakajima Y, Nagai K, Miyake S, Ohashi K, Kawano T, Iwai T. Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer. Jpn J Cancer Res. 2002;93:305-12.
9. Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus. 2009;6:1-25.
10. Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: part II and III. Esophagus. 2009;6:71-94.
11. Gockel I, Domeyer M, Sgourakis GG, Schimanski CC, Moehler M, Kirkpatrick CJ, et al. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining. J Surg Oncol. 2009;1(100):191-8.
12. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer. 2008;112:1239-46.
13. Jamieson GG, Thompson SK. Detection of lymph node metastases in oesophageal cancer. Br J Surg. 2009;96:21-5.
14. Tachimori Y, Nagai Y, Kanamori N, Hokamura N, Igaki H. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus. 2011;24:33-8.
15. Tsurumaru M, Kajiyama Y, Udagawa H, Akiyama H. Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus. Ann Thorac Cardiovasc Surg. 2001;7:325-9.
16. Motoyama S, Maruyama K, Sato Y, Usami S, Nakatsu T, Saito H, et al. Status of involved lymph nodes and direction of metastatic lymphatic flow between submucosal and T2-4 thoracic squamous cell esophageal cancers. World J Surg. 2009;33:512-7.
17. Motoyama S, Ishiyama K, Maruyama K, Okuyama M, Sato Y, Hayashi K, et al. Preoperative mapping of lymphatic drainage from the tumor using ferumoxide-enhanced magnetic resonance imaging in clinical submucosal thoracic squamous cell esophageal cancer. Surgery. 2007;141:736-47.
18. Kitagawa Y, Fujii H, Mukai M, Kubota T, Ando N, Ozawa S, et al. Intraoperative lymphatic mapping and sentinel lymph node sampling in esophageal and gastric cancer. Surg Oncol Clin N Am. 2002;11:293-304.
19. Takeuchi H, Fujii H, Ando N, Ozawa S, Saikawa Y, Suda K, et al. Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg. 2009;249:757-63.
20. Motoyama S, Miura M, Hinai Y, Maruyama K, Usami S, Saito H, et al. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer. Ann Surg Oncol. 2009;16:2479-85.
21. Kato H, Sato A, Fukuda H, Kagami Y, Udagawa H, Togo A, et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol. 2009;39:638-43.
22. Kurokawa Y, Muto M, Minashi K, Boku N, Fukuda H. Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group (JCOG). A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508. Jpn J Clin Oncol. 2009;39:686-9.